av-covid-19
Vaccineexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2020 (NCT04386252)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05007496 | Phase 2 | Apr 14, 2021 | AiVita Biomedical, Inc., Central Army Hospital RSPAD Gatot Soebroto, Diponegoro University, Rumah Sakit Pusat Angkatan Darat Gatot Soebroto |
| NCT04685603 | Phase 1 | Dec 7, 2020 | AiVita Biomedical, Inc., Diponegoro University, Government of Indonesia, Rumah Sakit Pusat Angkatan Darat Gatot Soebroto, Universitas Negeri Semarang |
| NCT04690387 | Phase 1 | Dec 7, 2020 | AiVita Biomedical, Inc., Government of Indonesia |
| NCT04386252 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2020 | AiVita Biomedical, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AiVita Biomedical, Inc. | For profit | 4 | 3 | 2 | 2020 |
| Diponegoro University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| Government of Indonesia | Government | 2 | 1 | 1 | 2020 |
| Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Government | 2 | 0 | 2 | 2020 |
| Central Army Hospital RSPAD Gatot Soebroto | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Universitas Negeri Semarang | Academic/Hospital | 1 | 0 | 1 | 2020 |
6 organizations
Page 1 / 1